Post-approval studies (Phase 4)Ended earlyNCT03208244
What this trial is testing
DAA Treatment in Donor HCV-positive to Recipient HCV-negative Heart Transplant
Who this might be right for
End Stage Heart DiseaseHepatitis C
Massachusetts General Hospital 40